Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities.
Stijn BekkersCorinne P DelsingSaskia E KokKaren van HulstCorrie E ErasmusArthur R T SchefferFrank J A van den HoogenPublished in: Neurology (2019)
This study provides Class III evidence that for children and adolescents with neurodevelopmental disabilities and severe drooling, 2-DL compared to a one-time intraglandular BoNT-A injection is more effective at reducing drooling at 32 weeks.